Yet due to safety concerns, the price and the large population of allergy sufferers, at first it was only approved for sufferers over 12 years old with moderate to severe asthma.
然而，基於安全性和藥價、過敏族群過於龐大等種種考量，初期只准許 12 歲以上、中重度的哮喘病患使用。